Backlash is brewing against a sweeping overhaul of Germany’s health insurance system as Eli Lilly and Boehringer Ingelheim slash investment in the country.
June 4, 2026 11:13 AM EDT
PharmaManufacturing
Germany’s health-spending plan has consequences as Lilly, Boehringer scale back
Ayisha Sharma
News Reporter
Lilly, Boehringer to slash at least $1B each from planned investments in Germany
Eli Lilly und Boehringer streichen Investitionen
Pharma-Großkonzerne Lilly und Boehringer stoppen Investitionen
Boehringer Ingelheim: Boehringer Ingelheim streicht geplante Investitionen in Deutschland
Boehringer und Eli Lilly: Pharma-Investitionsstopp rückt Ministerin Nina Warken in den Fokus
Eli Lilly und Boehringer streichen Investitionen - WELT
Nach Boehringer Ingelheim: Eli Lilly halbiert Milliardeninvestition in Deutschland
Wegen Spargesetz: Boehringer Ingelheim stoppt Investitionen in Deutschland
Pharmalittle: We're reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
Eli Lilly: US-Pharmakonzern halbiert Milliardeninvestition in Deutschland
